Your browser doesn't support javascript.
loading
In Vitro Evaluation and Mitigation of Niclosamide's Liabilities as a COVID-19 Treatment.
Wotring, Jesse W; McCarty, Sean M; Shafiq, Khadija; Zhang, Charles J; Nguyen, Theophilus; Meyer, Sophia R; Fursmidt, Reid; Mirabelli, Carmen; Clasby, Martin C; Wobus, Christiane E; O'Meara, Matthew J; Sexton, Jonathan Z.
Afiliación
  • Wotring JW; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.
  • McCarty SM; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.
  • Shafiq K; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.
  • Zhang CJ; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.
  • Nguyen T; Department of Internal Medicine, Gastroenterology and Hepatology, Michigan Medicine at the University of Michigan, Ann Arbor, MI 48109, USA.
  • Meyer SR; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.
  • Fursmidt R; Department of Internal Medicine, Gastroenterology and Hepatology, Michigan Medicine at the University of Michigan, Ann Arbor, MI 48109, USA.
  • Mirabelli C; Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA.
  • Clasby MC; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.
  • Wobus CE; Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA.
  • O'Meara MJ; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA.
  • Sexton JZ; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.
Vaccines (Basel) ; 10(8)2022 Aug 09.
Article en En | MEDLINE | ID: mdl-36016172

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos